HEADER TRANSFERASE 12-SEP-18 6HM7 TITLE CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2- TITLE 2 (PHENOXYMETHYL)PYRIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS SK363, SYK, NON-RECEPTOR TYROSINE KINASE, SPLEEN TYROSINE KINASE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.O.SOMERS REVDAT 3 01-MAY-24 6HM7 1 REMARK REVDAT 2 17-OCT-18 6HM7 1 JRNL REVDAT 1 10-OCT-18 6HM7 0 JRNL AUTH M.D.BARKER,J.LIDDLE,F.L.ATKINSON,D.M.WILSON,M.C.DICKSON, JRNL AUTH 2 C.RAMIREZ-MOLINA,H.LEWIS,R.P.DAVIS,D.O.SOMERS,M.NEU,E.JONES, JRNL AUTH 3 R.WATSON JRNL TITL DISCOVERY OF POTENT AND SELECTIVE SPLEEN TYROSINE KINASE JRNL TITL 2 INHIBITORS FOR THE TOPICAL TREATMENT OF INFLAMMATORY SKIN JRNL TITL 3 DISEASE. JRNL REF BIOORG. MED. CHEM. LETT. V. 28 3458 2018 JRNL REFN ESSN 1464-3405 JRNL PMID 30249354 JRNL DOI 10.1016/J.BMCL.2018.09.022 REMARK 2 REMARK 2 RESOLUTION. 1.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 31597 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1683 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.64 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.68 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2357 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE SET COUNT : 102 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2175 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 326 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.23000 REMARK 3 B22 (A**2) : -1.81000 REMARK 3 B33 (A**2) : -1.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.43000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.099 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.100 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.086 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.688 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2285 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2085 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3087 ; 1.406 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4838 ; 0.896 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 272 ; 4.468 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 104 ;35.079 ;24.327 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 405 ;11.074 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;15.431 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 321 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2554 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 466 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6HM7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1200011903. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.0.6 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33320 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.640 REMARK 200 RESOLUTION RANGE LOW (A) : 42.446 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06500 REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.64 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.49100 REMARK 200 R SYM FOR SHELL (I) : 0.49100 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: OTHER IN-HOUSE COORDINATES REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, BISTRISPROPANE, SODIUM REMARK 280 BROMIDE, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.44600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 HIS A 531 REMARK 465 GLY A 532 REMARK 465 LYS A 533 REMARK 465 VAL A 634 REMARK 465 ASN A 635 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 405 CG CD CE NZ REMARK 470 GLU A 407 CG CD OE1 OE2 REMARK 470 THR A 530 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 809 O HOH A 961 1.89 REMARK 500 NZ LYS A 537 O HOH A 801 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 392 -168.87 -100.62 REMARK 500 ALA A 441 -145.52 -137.95 REMARK 500 ASP A 494 39.79 -147.64 REMARK 500 ASP A 512 73.15 64.31 REMARK 500 ASP A 512 73.15 66.28 REMARK 500 TRP A 609 32.37 -91.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1126 DISTANCE = 6.19 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GDH A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BR A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BR A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BR A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 706 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6HM6 RELATED DB: PDB DBREF 6HM7 A 360 635 UNP P43405 KSYK_HUMAN 337 612 SEQRES 1 A 276 PRO LYS GLU VAL TYR LEU ASP ARG LYS LEU LEU THR LEU SEQRES 2 A 276 GLU ASP LYS GLU LEU GLY SER GLY ASN PHE GLY THR VAL SEQRES 3 A 276 LYS LYS GLY TYR TYR GLN MET LYS LYS VAL VAL LYS THR SEQRES 4 A 276 VAL ALA VAL LYS ILE LEU LYS ASN GLU ALA ASN ASP PRO SEQRES 5 A 276 ALA LEU LYS ASP GLU LEU LEU ALA GLU ALA ASN VAL MET SEQRES 6 A 276 GLN GLN LEU ASP ASN PRO TYR ILE VAL ARG MET ILE GLY SEQRES 7 A 276 ILE CYS GLU ALA GLU SER TRP MET LEU VAL MET GLU MET SEQRES 8 A 276 ALA GLU LEU GLY PRO LEU ASN LYS TYR LEU GLN GLN ASN SEQRES 9 A 276 ARG HIS VAL LYS ASP LYS ASN ILE ILE GLU LEU VAL HIS SEQRES 10 A 276 GLN VAL SER MET GLY MET LYS TYR LEU GLU GLU SER ASN SEQRES 11 A 276 PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU LEU SEQRES 12 A 276 VAL THR GLN HIS TYR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 13 A 276 SER LYS ALA LEU ARG ALA ASP GLU ASN PTR TYR LYS ALA SEQRES 14 A 276 GLN THR HIS GLY LYS TRP PRO VAL LYS TRP TYR ALA PRO SEQRES 15 A 276 GLU CYS ILE ASN TYR TYR LYS PHE SER SER LYS SER ASP SEQRES 16 A 276 VAL TRP SER PHE GLY VAL LEU MET TRP GLU ALA PHE SER SEQRES 17 A 276 TYR GLY GLN LYS PRO TYR ARG GLY MET LYS GLY SER GLU SEQRES 18 A 276 VAL THR ALA MET LEU GLU LYS GLY GLU ARG MET GLY CYS SEQRES 19 A 276 PRO ALA GLY CYS PRO ARG GLU MET TYR ASP LEU MET ASN SEQRES 20 A 276 LEU CYS TRP THR TYR ASP VAL GLU ASN ARG PRO GLY PHE SEQRES 21 A 276 ALA ALA VAL GLU LEU ARG LEU ARG ASN TYR TYR TYR ASP SEQRES 22 A 276 VAL VAL ASN MODRES 6HM7 PTR A 525 TYR MODIFIED RESIDUE HET PTR A 525 16 HET GDH A 701 28 HET BR A 702 1 HET BR A 703 1 HET BR A 704 1 HET GOL A 705 6 HET DMS A 706 4 HETNAM PTR O-PHOSPHOTYROSINE HETNAM GDH 7-[2-METHOXY-6-[(4-METHYLPYRIDIN-2-YL)METHOXY]PHENYL]- HETNAM 2 GDH 2,3,4,5-TETRAHYDRO-1~{H}-3-BENZAZEPINE HETNAM BR BROMIDE ION HETNAM GOL GLYCEROL HETNAM DMS DIMETHYL SULFOXIDE HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 GDH C24 H26 N2 O2 FORMUL 3 BR 3(BR 1-) FORMUL 6 GOL C3 H8 O3 FORMUL 7 DMS C2 H6 O S FORMUL 8 HOH *326(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 ASP A 410 LEU A 427 1 18 HELIX 3 AA3 LEU A 456 GLN A 462 1 7 HELIX 4 AA4 LYS A 467 SER A 488 1 22 HELIX 5 AA5 ALA A 496 ARG A 498 5 3 HELIX 6 AA6 PRO A 535 TYR A 539 5 5 HELIX 7 AA7 ALA A 540 TYR A 547 1 8 HELIX 8 AA8 SER A 550 SER A 567 1 18 HELIX 9 AA9 LYS A 577 LYS A 587 1 11 HELIX 10 AB1 PRO A 598 TRP A 609 1 12 HELIX 11 AB2 ASP A 612 ARG A 616 5 5 HELIX 12 AB3 GLY A 618 VAL A 633 1 16 SHEET 1 AA1 3 LEU A 370 LEU A 372 0 SHEET 2 AA1 3 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 AA1 3 GLY A 378 SER A 379 -1 N GLY A 378 O VAL A 385 SHEET 1 AA2 5 LEU A 370 LEU A 372 0 SHEET 2 AA2 5 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 AA2 5 VAL A 396 LEU A 404 -1 O ILE A 403 N THR A 384 SHEET 4 AA2 5 TRP A 444 GLU A 449 -1 O TRP A 444 N LEU A 404 SHEET 5 AA2 5 MET A 435 GLU A 440 -1 N GLY A 437 O VAL A 447 SHEET 1 AA3 3 GLY A 454 PRO A 455 0 SHEET 2 AA3 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA3 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 AA4 2 PHE A 490 VAL A 491 0 SHEET 2 AA4 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA5 2 TYR A 526 LYS A 527 0 SHEET 2 AA5 2 LYS A 548 PHE A 549 -1 O PHE A 549 N TYR A 526 LINK C ASN A 524 N PTR A 525 1555 1555 1.34 LINK C PTR A 525 N TYR A 526 1555 1555 1.33 SITE 1 AC1 13 LEU A 377 VAL A 385 ALA A 400 MET A 448 SITE 2 AC1 13 GLU A 449 ALA A 451 GLY A 454 PRO A 455 SITE 3 AC1 13 ARG A 498 ASN A 499 LEU A 501 ASP A 512 SITE 4 AC1 13 HOH A 827 SITE 1 AC2 2 ARG A 367 LEU A 372 SITE 1 AC3 4 PRO A 535 VAL A 536 LYS A 537 HOH A1104 SITE 1 AC4 3 ARG A 498 HOH A 863 HOH A1030 SITE 1 AC5 7 LYS A 469 ASN A 470 GLU A 473 HIS A 506 SITE 2 AC5 7 TYR A 630 HOH A 874 HOH A 878 SITE 1 AC6 2 TYR A 431 HOH A 867 CRYST1 41.114 84.892 40.361 90.00 100.16 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024323 0.000000 0.004357 0.00000 SCALE2 0.000000 0.011780 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025171 0.00000